IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BB Biotech AG

Q3 2017 Holdings

Filed 2017-11-13 | 27 holdings | $317.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Agios Pharmaceuticals Inc.(AGIO)COM00847X104$183.6M2,749,99857.8%
Alnylam Pharmaceuticals Inc.(ALNY)COM02043Q107$130.6M1,111,33841.1%
Celgene Corp(CELG)COM151020104$464.3K3,184,2980.1%
Incyte Corp.(INCY)COM45337C102$428.2K3,668,3220.1%
Ionis Pharmaceuticals Inc.(IONS)COM462222100$398.6K7,861,9340.1%
Gilead Sciences Inc.(GILD)COM375558103$224.8K2,774,5960.1%
Vertex Pharmaceuticals Inc.(VRTX)COM92532F100$224.3K1,475,4450.1%
Neurocrine Biosciences Inc.(NBIX)COM64125C109$212.2K3,462,7530.1%
Radius Health Inc.COM750469207$212.0K5,498,7990.1%
Alexion Pharmaceuticals Inc.(ALXN)COM015351109$190.0K1,354,4280.1%
Halozyme Therapeutics Inc.(HALO)COM40637H109$149.8K8,626,0510.0%
Tesaro Inc.COM881569107$128.6K996,1930.0%
Esperion Therapeutics Inc.(ESPR)COM29664W105$105.2K2,097,9640.0%
Juno Therapeutics Inc.COM48205A109$92.2K2,055,0000.0%
Regeneron Pharmaceuticals Inc.(REGN)COM75886F107$91.7K205,0000.0%
Sage Therapeutics Inc.(SG7)COM78667J108$68.1K1,092,4390.0%
Myovant Sciences Ltd.COMG637AM102$53.8K3,477,8820.0%
MacroGenics Inc.(MGNX)COM556099109$44.4K2,400,4120.0%
AveXis, Inc.COM05366U100$39.0K402,8000.0%
Intra-Cellular Therapies Inc.(ITCIEUR)COM46116X101$34.7K2,200,0000.0%
Five Prime Therapeutics Inc.(FPRX)COM33830X104$31.8K777,5000.0%
Intercept Pharmaceuticals Inc.(ICPTUSD)COM45845P108$28.2K485,7190.0%
Alder Biopharmaceuticals Inc.(ALDR1EUR)COM014339105$27.8K2,266,0080.0%
Prothena Corp. PLC(PRTA)COMG72800108$22.7K350,0000.0%
Cidara Therapeutics Inc.COM171757107$10.8K1,335,2720.0%
Novavax Inc.COM670002104$9.5K8,330,0000.0%
Achillion Pharmaceuticals Inc.(ACHNEUR)COM00448Q201$5.7K1,279,3400.0%